EMA Decision Time For GSK’s RSV Older Adult Vaccine & Roche’s Glofitamab For LBCL

A number of companies could soon find out whether the European Medicines Agency will back pan-EU marketing approval for their respective products.

RSV vaccine
GSK's RSV vaccine for older adults is among the products that are up for a CHMP opinion this week • Source: Shutterstock

Roche, Eli Lilly and Taiho Pharmaceutical could this week learn whether the European Medicines Agency will recommend in favor of approving the EU marketing applications for their respective orphan drugs, glofitamab, pirtobrutinib and futibatinib.

Their products are among the drugs listed as being up for an opinion on the draft agenda of the...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography